Observational analysis demonstrated effective dose monitoring in carbon-ion radiotherapy using LYSO-SiPM PET, suggesting improved patient outcomes.
Objective: In-beam PET is a promising approach for dose monitoring in carbon-ion radiotherapy (CIRT). This study evaluated the feasibility of a dual-head PET system using LYSO scintillators and SiPM detectors incorporating time-of-flight(TOF) technology to monitor carbon-ion beam dose distribution. Approach: The dual-head PET system includes four modules per head, each comprising a 12 × 12 array of LYSO crystals (4.14 mm × 4.14 mm × 20 mm) coupled with SiPM detectors. TOF information was integrated into image reconstruction using a TOF-MLEM algorithm to enhance spatial resolution and reduce noise, especially along the panel-to-panel (X-axis) direction. Two configurations were used: (1) a 4 × 1 module for single-energy beams (120.12–280.56 MeV/u) and multi-energy beams (178.87, 190.19, 201.03 MeV/u), and (2) a 2 × 2 module for 20 mm × 20 mm field measurements using a 151.32 MeV/u beam. During the 5-second spill-off in-beam phase, the system detected 511 keV γ-rays from positron annihilation while suppressing prompt γ-ray interference. Analysis included 48 in-beam periods of 261.03 MeV/u carbon ions, divided into eight groups, and Monitor Units (MU) estimates were based on the PET image peak intensity. Main Results: In-beam PET imaging showed peak depth increased with beam energy, from 29.9 mm (120.12 MeV/u) to 132.0 mm (280.56 MeV/u). For multi-energy beams, three distinct peaks corresponded to different energies (178.87, 190.19, and 201.03 MeV/u). The 20 mm × 20 mm field measurements showed FWHM) values of 20.42 mm (X-axis) and 19.76 mm (Y-axis), with a 45.6 mm peak depth (Z-axis) consistent with the single-energy results. PET-based MU estimation with a 261.03 MeV/u beam showed decreasing relative error with more beam periods, reaching a stable value around 1% after 12 periods.. Significance: In-beam PET offers a robust solution for dose monitoring and verification in CIRT, supporting precise dose delivery and better patient outcomes.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: